Ruiz-Moreno, José M. http://orcid.org/0000-0001-9636-0788
Ruiz-Medrano, Jorge
Funding for this research was provided by:
AbbVie
Article History
Received: 27 June 2022
Revised: 21 October 2022
Accepted: 25 October 2022
First Online: 12 November 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethic Committee of the Puerta de Hierro-Majadahonda University Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Due to the characteristics of the study, the Ethic Committee of the Puerta de Hierro-Majadahonda University Hospital waived the need for written informed consent.
: Dr Ruiz-Moreno has received a grant from Allergan during the conduct of the study. Neither honoraria nor payments were made for authorship of this article. Dr Ruiz-Medrano certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.